However, our mouse models failed to display higher levels of circulating androgens or AMH, two of the hallmarks of PCOS (Dewailly et al., 2020), suggesting that melanocortin signaling is unlikely to be a main contributing factor in the development of this syndrome. This evidence concerns the gene AMH and polycystic ovary syndrome.